(Total Views: 476)
Posted On: 02/22/2021 9:28:17 AM
Post# of 145254
![Avatar](https://investorshangout.com/images/ProfileImages/573000060_60093_FD245EF6-37BD-4C88-9356-29519D0376AD.jpeg)
Re: Evil Rabbit #79121
Here’s why I’m confused: if the primary endpoint was met, why not PR that? Instead we as investors have to wait until regulatory discussions are complete to get a PR? No biotech or BP ever has reached their primary endpoint but delayed releasing that because of discussions with the FDA.
My thought: 28 day mortality failed BUT mortality at 42 days or X days was stat sig reduced. CYDY is going to shop that data around for approval. No reason to shop around primary endpoint that is met.
My thought: 28 day mortality failed BUT mortality at 42 days or X days was stat sig reduced. CYDY is going to shop that data around for approval. No reason to shop around primary endpoint that is met.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)